News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
583,261 Results
Type
Article (19113)
Company Profile (170)
Press Release (563974)
Multimedia
Podcasts (79)
Webinars (13)
Section
Business (198425)
Career Advice (699)
Deals (30760)
Drug Delivery (95)
Drug Development (65631)
Employer Resources (55)
FDA (12404)
Job Trends (11099)
News (287861)
Policy (24136)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (826)
Accelerated approval (47)
ADA (26)
Adcomms (10)
Allergies (148)
Alliances (41810)
ALS (154)
Alzheimer's disease (1291)
Antibody-drug conjugate (ADC) (379)
Approvals (13107)
Artificial intelligence (551)
ASCO (219)
Autoimmune disease (274)
Automation (43)
Bankruptcy (321)
Belgium (3)
Best Places to Work (8366)
BIO (47)
Biologics (11)
BIOSECURE Act (10)
Biosimilars (199)
BioSpace Insights (79)
Biotechnology (105)
Bispecific (1)
Bladder cancer (157)
Brain cancer (60)
Breast cancer (621)
Cancer (4667)
Cardiovascular disease (373)
Career advice (609)
Career pathing (15)
CAR-T (227)
CDC (9)
CDMO (78)
Celiac Disease (2)
Cell therapy (632)
Cervical cancer (42)
Clinical research (59185)
Collaboration (1798)
Commercialization (6)
Company closure (3)
Compensation (1567)
Complete response letters (61)
COVID-19 (1293)
CRISPR (84)
C-suite (1155)
Cystic fibrosis (128)
Data (6973)
Decentralized trials (1)
Denatured (23)
Depression (131)
Dermatology (80)
Diabetes (467)
Diagnostics (4883)
Digital health (46)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (282)
Drug pricing (128)
Drug shortages (15)
Duchenne muscular dystrophy (234)
Earnings (81480)
Editorial (25)
Employer branding (5)
Employer resources (51)
Events (99873)
Executive appointments (995)
FDA (15767)
Fibrodysplasia Ossificans Progressiva (11)
Friedreich's ataxia (21)
Frontotemporal dementia (29)
Funding (1290)
Gene editing (166)
Generative AI (38)
Gene therapy (482)
GLP-1 (684)
Government (2023)
Grass and pollen (5)
Guidances (332)
Healthcare (11091)
Hematology (128)
HIV (58)
Huntington's disease (29)
IgA nephropathy (108)
Immunology and inflammation (181)
Immuno-oncology (84)
Indications (205)
Infectious disease (1531)
Inflammatory bowel disease (177)
Inflation Reduction Act (9)
Influenza (99)
Intellectual property (310)
Interviews (93)
IPO (13983)
IRA (33)
Job creations (3105)
Job search strategy (551)
JPM (29)
Kidney cancer (21)
Kidney disease (67)
Labor market (43)
Layoffs (255)
Leadership (12)
Legal (6580)
Licensing (28)
Liver cancer (56)
Longevity (30)
Lung cancer (685)
Lymphoma (355)
Machine learning (37)
Management (19)
Manufacturing (1001)
Marketing (12)
MASH (166)
Medical affairs (3)
Medical device (9294)
Medtech (9465)
Mergers & acquisitions (18000)
Metabolic disorders (1110)
mRNA (122)
Multiple sclerosis (145)
NASH (15)
Neurodegenerative disease (311)
Neuropsychiatric disorders (76)
Neuroscience (2522)
Neurotech (1)
NextGen: Class of 2026 (3893)
Non-profit (1259)
Now hiring (27)
Obesity (445)
Opinion (159)
Ovarian cancer (180)
Pain (260)
Pancreatic cancer (239)
Parkinson's disease (287)
Partnered (23)
Patents (618)
Patient recruitment (634)
Patient selection (7)
Peanut (40)
People (50913)
Peptides (5)
Pharmaceutical (46)
Pharmacy benefit managers (24)
Phase 1 (18229)
Phase 2 (26011)
Phase 3 (19345)
Pipeline (9408)
Policy (168)
Postmarket research (2126)
Preclinical (7560)
Press Release (49)
Prostate cancer (240)
Psychedelics (35)
Radiopharmaceuticals (284)
Rare diseases (892)
Real estate (4466)
Recruiting (20)
Regenerative medicine (6)
Regulatory (20009)
Reports (30)
Research institute (962)
Resumes & cover letters (94)
Rett syndrome (43)
RNA editing (12)
RSV (53)
Schizophrenia (153)
Series A (237)
Series B (160)
Service/supplier (5)
Sickle cell disease (98)
Special edition (13)
Spinal muscular atrophy (116)
Sponsored (17)
Startups (2786)
State (2)
Stem cells (1)
Stomach cancer (9)
Substance use disorders (17)
Supply chain (97)
Tariffs (71)
The Weekly (54)
Vaccines (531)
Venture capital (61)
Weight loss (231)
Women's health (114)
Worklife (4)
Date
Today (23)
Last 7 days (373)
Last 30 days (1732)
Last 365 days (23127)
2026 (17074)
2025 (23291)
2024 (27244)
2023 (31375)
2022 (40745)
2021 (43341)
2020 (39851)
2019 (29679)
2018 (22618)
2017 (24679)
2016 (23524)
2015 (29412)
2014 (25668)
2013 (22071)
2012 (24093)
2011 (24438)
2010 (23670)
Location
Africa (468)
Alabama (88)
Alaska (2)
Arizona (345)
Arkansas (13)
Asia (30313)
Australia (4173)
California (13165)
Canada (3588)
China (1107)
Colorado (532)
Connecticut (491)
Delaware (287)
Europe (54917)
Florida (2025)
Georgia (423)
Hawaii (3)
Idaho (49)
Illinois (895)
India (104)
Indiana (578)
Iowa (17)
Japan (601)
Kansas (122)
Kentucky (40)
Louisiana (32)
Maine (28)
Maryland (1412)
Massachusetts (9027)
Michigan (333)
Minnesota (619)
Mississippi (5)
Missouri (107)
Montana (27)
Nebraska (16)
Nevada (126)
New Hampshire (68)
New Jersey (3318)
New Mexico (18)
New York (3217)
North Carolina (1579)
North Dakota (4)
Northern California (6624)
Ohio (323)
Oklahoma (17)
Oregon (29)
Pennsylvania (2472)
Puerto Rico (30)
Rhode Island (36)
South America (732)
South Carolina (82)
South Dakota (1)
Southern California (5440)
Tennessee (153)
Texas (2131)
United States (44519)
Utah (404)
Vermont (1)
Virginia (280)
Washington D.C. (52)
Washington State (1023)
West Virginia (2)
Wisconsin (111)
Wyoming (2)
583,261 Results for "ampio pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Ampio Provides Update on Results from Pre-IND Enabling Studies
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”) today announced the efficacy results from recently completed nonclinical pre-IND enabling studies with OA-201, Ampio’s only product development opportunity.
February 14, 2024
·
3 min read
BioMidwest
Ampio Pharmaceuticals Announces Reverse Stock Split
Ampio Pharmaceuticals, Inc. announced that its Board of Directors has approved a 20-to-1 reverse stock split of the Company’s common stock.
August 31, 2023
·
4 min read
BioMidwest
Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation
Ampio Pharmaceuticals, Inc. announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2023, which was filed on March 27, 2024 with the Securities and Exchange Commission, the audited financial statements contained an unqualified audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Company’s ability to continue as a going concern.
April 3, 2024
·
1 min read
Press Releases
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend - September 17, 2026
September 17, 2026
·
8 min read
Policy
Ampio Announces Voluntary Delisting and SEC Deregistration
Ampio Pharmaceuticals, Inc. announced that its Board of Directors determined to voluntarily delist its common stock from the NYSE American and deregister its common stock in order to terminate and suspend its reporting obligations under the Securities and Exchange Act of 1934, as amended.
March 25, 2024
·
4 min read
Press Releases
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
August 5, 2026
·
3 min read
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company) today announced that it has selected Ascendia Pharmaceuticals, Inc. (“Ascendia”) to provide services to support the clinical development of OA-201, a novel therapeutic for the treatment of symptomatic osteoarthritis pain.
October 5, 2023
·
5 min read
BioMidwest
Ampio Pharmaceuticals Issues Letter to Stockholders - April 18, 2023
Ampio Pharmaceuticals, Inc. released the following letter to stockholders from its Chairman, Kevin Buchi and Chief Executive Officer, Mike Martino.
April 18, 2023
·
7 min read
Ampio Pharmaceuticals to Present at the Emerging Growth Conference
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company”) a pre-revenue stage biopharmaceutical Company focused on development of a potential treatment for osteoarthritis as part of its OA.201 program, today announced that its CEO, Michael A. Martino will present in the Emerging Growth Conference on Thursday, October 5, 2023 at 3:25 pm ET.
September 26, 2023
·
3 min read
Press Releases
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 28, 2026
·
5 min read
1 of 58,327
Next